1.
MTA2表达与NSCLC患者临床病理因素之间的关系
Relationship between expression of MTA2 and clinico-pathological factors in NSCLC
| Characteristics | n | Expression of MTA2 | r | P | |
| + | - | ||||
| Age | -0.003 | 0.972 | |||
| ≥55 | 60 | 35 | 25 | ||
| < 55 | 50 | 29 | 21 | ||
| Gender | -0.031 | 0.749 | |||
| Male | 57 | 34 | 23 | ||
| Female | 53 | 30 | 23 | ||
| Histological type | 0.034 | 0.721 | |||
| Squamous cell carcinoma | 48 | 27 | 21 | ||
| Adenocarcinoma | 62 | 37 | 25 | ||
| Differentiation | -0.440 | < 0.001 | |||
| Highly and moderately differentiated | 46 | 15 | 31 | ||
| Poorly differentiated | 64 | 49 | 15 | ||
| Lymphoid node metastasis | 0.299 | 0.001 | |||
| N0 | 50 | 21 | 29 | ||
| N1-2 | 60 | 43 | 17 | ||
| P-TNM stage | 0.256 | 0.007 | |||
| Ⅰ/Ⅱ | 65 | 31 | 34 | ||
| Ⅲ/Ⅳ | 45 | 33 | 12 | ||